We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Won't Add Black Box Warning To Blood Thinner Plavix

Law360 (January 10, 2019, 7:07 PM EST) -- The U.S. Food and Drug Administration has shot down a 5-year-old request from Public Citizen to add a black box warning to Bristol-Myers Squibb and Sanofi-Aventis' blood thinner Plavix and its generic counterparts,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.